- Home
- TECH vs ORKT Comparison
TECH vs ORKT Comparison
Compare TECH & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- ORKT
- Stock Information
- Founded
- TECH 1976
- ORKT 2003
- Country
- TECH United States
- ORKT Singapore
- Employees
- TECH N/A
- ORKT N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- ORKT
- Sector
- TECH Health Care
- ORKT
- Exchange
- TECH Nasdaq
- ORKT NYSE
- Market Cap
- TECH 8.0B
- ORKT N/A
- IPO Year
- TECH 1989
- ORKT 2024
- Fundamental
- Price
- TECH $48.10
- ORKT $0.56
- Analyst Decision
- TECH Buy
- ORKT Strong Buy
- Analyst Count
- TECH 9
- ORKT 1
- Target Price
- TECH $81.25
- ORKT $5.00
- AVG Volume (30 Days)
- TECH 2.2M
- ORKT 108.8K
- Earning Date
- TECH 05-07-2025
- ORKT 01-01-0001
- Dividend Yield
- TECH 0.63%
- ORKT N/A
- EPS Growth
- TECH N/A
- ORKT N/A
- EPS
- TECH 0.98
- ORKT N/A
- Revenue
- TECH $1,196,016,000.00
- ORKT $3,904,592.00
- Revenue This Year
- TECH $8.19
- ORKT N/A
- Revenue Next Year
- TECH $8.85
- ORKT $39.99
- P/E Ratio
- TECH $49.09
- ORKT N/A
- Revenue Growth
- TECH 4.46
- ORKT N/A
- 52 Week Low
- TECH $46.44
- ORKT $0.56
- 52 Week High
- TECH $85.57
- ORKT $8.00
- Technical
- Relative Strength Index (RSI)
- TECH 33.97
- ORKT N/A
- Support Level
- TECH $46.44
- ORKT N/A
- Resistance Level
- TECH $53.00
- ORKT N/A
- Average True Range (ATR)
- TECH 3.30
- ORKT 0.00
- MACD
- TECH -0.27
- ORKT 0.00
- Stochastic Oscillator
- TECH 13.00
- ORKT 0.00
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.